Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Takeda H1 EPS Surges, Revenue Up 8.4%; Upgrades FY26 Outlook

(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK), Thursday reported a 171.8 percent surge in first half earnings compared to the prior year. Looking ahead to the full year 2026, the company raised its outlook.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

Gen Digital: 3 Key Takeaways for Long-Term Investors

AI automation and partner channel expansion are generating the margin lift and cash flow that let management skip transformative M&A.

  • Gen Digital reported double-digit revenue growth and strong cash flow in Q2 2027
  • Partner channel now accounts for over 20% of total revenue
  • CEO Vincent Pilette emphasizes focus on organic growth and cost advantages

More from Thursday 29 October →